MAPS is a nonprofit organization that conducts research and education on psychedelics.

MAPS

Psychedelic Science

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

We further our mission by:

● Developing psychedelics and marijuana into prescription medicines
● Training therapists and working to establish a network of treatment centers
● Supporting scientific research into spirituality, creativity, and neuroscience
● Educating the public honestly about the risks and benefits of psychedelics and marijuana

Multidisciplinary Association for Psychedelic Studies (MAPS)

Join MAPS at SXSW as we explore how breakthrough research and a growing business environment will impact the future applications of novel and traditional substances.

Swipe to see presentations featuring Rick Doblin, Ph.D., and Julie Holland, MD, that you won't want to miss! 💫

MAPS Welcomes New Investors and a Name Change for MAPS PBC, now Lykos.

A decade after it was founded as a wholly owned subsidiary of MAPS, MAPS Public Benefit Corporation (MAPS PBC) has announced the successful close of an oversubscribed Series A financing of more than $100 million, led by Helena, alongside a name change to Lykos Therapeutics and new visual identity.

https://lnkd.in/gbimDEqF

We're Backkkkkk ✨ 

🌟 Save the Date! 🌟 Join us in Denver, Colorado, from June 16–20, 2025, for the 5th edition of the Psychedelic Science conference! ✨ MAPS is thrilled to return to The Mile High City for another incredible week of learning and connection. 

Psychedelic Science covers the full spectrum of psychedelics, including science, medicine, policy, business, spirituality, and culture. It is welcoming to all community members, whether you are newly curious or decades into your journey.🎉

Don't miss out - mark your calendars now!

Sign up for the Psychedelic Science mailing list to be the first to know as details are released and registration opens.

https://lnkd.in/ewq5uPxP

Viewport Meta

IPhone / Mobile Compatible

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

Google Font API

Google Analytics

DNSSEC

Content Delivery Network

WordPress

Robert Barnhart

Joby Pritzker

John Gilmore

David Bronner

Rick Doblin

Founder & Executive Director

Reid Robison

Coordinating Investigator

Bryson Voirin

Chief Of Staff

Eric Sienknecht

Sub-investigator, Supervisor, and Assistant Trainer

Federico Menapace

Chief Strategy Officer

Amy Emerson

California Companies With Less Than $1B in Revenue (Top 10K)

Western US Companies With Less Than $1B in Revenue (Top 10K)

Non Profit Companies With Fewer Than 1000 Employees (Top 10K)

San Francisco Bay Area Companies With More Than 50 Employees (Top 10K)

MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. The organization is focused on developing psychedelics and marijuana into prescription medicines, training therapists and working to establish a network of treatment centers, supporting scientific research into spirituality, creativity, and neuroscience, and educating the public honestly about the risks and benefits of psychedelics and marijuana.

MAPS was founded in 1986 by Rick Doblin and is headquartered in Santa Cruz, California.

Funding Round - Multidisciplinary Association for Psychedelic Studies

Grant - Multidisciplinary Association for Psychedelic Studies

Santa Cruz

California

United States

North America

Multidisciplinary Association for Psychedelic Studies

MAPS Successfully Clears Path for Cannabis Research through FDA Formal Dispute

After FDA setback, psychedelic drugmakers distance themselves from a pioneer

Turning a ‘no’ vote into progress: How to advance MDMA-assisted psychotherapy for PTSD

FDA advisors voted against MDMA therapy – researchers are still fighting for it

Turning a 'no' vote into progress: How to advance MDMA-assisted psychotherapy for PTSD

Pyschedelic drug boosters assess challenges after FDA panel turns thumbs down on MDMA

What Is MDMA Therapy for PTSD? And What Are Its Risks?

F.D.A. Panel Rejects MDMA-Aided Therapy for PTSD

MAPS psychedelics research for MDMA therapy comes under scrutiny : Shots - Health News

Transformation or trouble? Research into MDMA plagued with allegations of misconduct

Research into the use of psychedelics, including MDMA, for therapeutic purposes, particularly for the treatment of PTSD.

Educational programs and resources on the use of psychedelics and their therapeutic potential.

Efforts to inform the public and policymakers about psychedelics and advocate for policy reform.

A resource on providing care for individuals experiencing difficult psychedelic experiences, with proceeds supporting psychedelic peer support.

A comprehensive work by Stanislav Grof on the exploration of consciousness and the therapeutic potential of psychedelics.

A guide to the global literature on the spiritual uses of ayahuasca and its religious movements.

Brazil

South America

Germany

Europe

France

Iceland

HTML5

Lightbox

Google Drive

Google Maps API

Comodo PositiveSSL Certificates

Wordpress

Facebook

Facebook Comments

Matomo (Formerly Piwik)

Amazon EC2

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 7, 2024 6:38 PM	afc9ec42
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	f760d85a
crunchbase profile	general	Nov 22, 2024 3:29 PM	0e678543
li profile	general	Aug 7, 2024 6:38 PM	e1160117
translate crunchbase fundingrounds	general	Nov 22, 2024 5:59 PM	3d49d700
peers	general	Aug 7, 2024 6:38 PM	1a36984e
news basic	general	Aug 7, 2024 6:38 PM	00d3e458
bundesanzeiger	filings
financials download nd	financials
private financials	financials

MAPS

ORG:MAPS

MAPS